Add To Watchlist
Share URL
Oxford Nanopore Technologies plc
ONT.L: LSELowest reading is at 11 out of 100. All scores are out of 100.
In Short
About The Company
CEO
Mr. Francis Albert Luc Van Parys
Market Cap
1.78 Billion GBp
Sector
Healthcare
Website
https://nanoporetech.comLast Update
28/09/2026, 03:18:34
Description
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
Read More
Strongest readings
- ✔Debt is low at 0.09 times equity
Weakest readings
- ✘Income is not covering expenditure and investment (free cashflow -0.12 per share)
- ✘Earnings are negative at -0.15 per share
- ✘Returns on capital have declined over five years (8.09% lower)
- ✘Share count has been rising at 5.27% per year
- ✘Priced well above the cashflow it produces (value score 11 out of 100)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
Price / earnings (TTM) | N/A | 19.60x | ||
| ✘ | Margin of safety (DCF) | -76.11% | 17.95% | |
| ✘ | Revenue growth (5y average) | 7.98% | 10.97% | |
| ✘ | Dividend yield (TTM) | 0.00% | 1.85% | |
| ✘ | Share count, per year | 5.27% | 0.00% | |
| ✘ | Return on capital employed | -27.18% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
11 / 100Priced above the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
Price / earnings | N/A | 19.60x | ||
| ✘ | Free cashflow yield | -6.66% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | 418.57x | — | ||
| ✘ | Margin of safety | -76.11% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 43.39 GBp is below the current price of 181.60 GBp
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: N/A✘
Current Price: 181.6 GBp
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
41 / 100Growing more slowly than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Revenue growth | 7.98% | 10.97% | |
| Earnings growth | N/A | 14.48% | ||
| Cashflow growth | N/A | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Health
36 / 100Balance sheet is stretched on several measures.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✘ | Altman-Z score | 0.00 | 3.00 | |
| ✘ | Piotroski score | 3.00 | 5.00 | |
| ✔ | Debt / equity | 0.09x | 0.80x | |
| ✔ | Current ratio | 3.56x | 1.00x | |
| ✘ | Interest coverage | -48.96x | 2.50x | |
| ✘ | Free cashflow / debt | 0.00x | 0.15x | |
| ✔ | Debt / capital | 0.08x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Income is not covering expenditure and investment (free cashflow -0.12 per share)
Management
17 / 100Returns on capital are below the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Return on equity | -31.34% | 15.00% | |
| ✘ | Return on capital employed | -27.18% | 10.00% | |
| Return on assets | -23.33% | — | ||
| Free cashflow return on capital | -23.05% | — | ||
| ✘ | Return on capital, 5y change | -8.09% | 0.00% | |
| ✘ | Share count, per year | 5.27% | 0.00% | |
| ✘ | Share count, recent | 1.72% | 0.00% | |
| Realized buyback return | N/A | 0.00% | ||
| ✔ | Goodwill erosion / equity | 0.00% | 2.00% | |
| Price volatility, 5 year | 56.97% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔New shares were issued while the value score was 11 out of 100
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
ONT.L
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
Oxford Nanopore Technologies plc
Currency
GBp
Beta
0.964
Vol Avg
2177625
Ceo
Mr. Francis Albert Luc Van Parys
Cik
Cusip
Exchange
LSE
Full Time Employees
1314
Industry
Biotechnology
Sector
Healthcare
Ipo Date
Address
Gosling Building
City
Oxford
State
Country
United Kingdom
Zip
OX4 4DQ
Phone
44 80 8502 3445
Analysis Last Updated
28/09/2026, 03:18:34
Financial data compiled from SEC EDGAR filings and Yahoo Finance.